Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Warner-Lambert Cerebyx relabeled product offered to wholesalers to reduce dosing confusion.

Executive Summary

WARNER-LAMBERT OFFERING EXCHANGE OF NEWLY LABELED CEREBYX TO WHOLESALERS for existing inventory of the anticonvulsant. The company has revised the packaging of Cerebyx (fosphenytoin) to emphasize dosing in phenytoin (Dilantin) equivalents. A labeling supplement for the phenytoin prodrug was approved on Dec. 26. Cerebyx was approved in August.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029661

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel